Felsher DW - Search Results

1

MYC activation is a hallmark of cancer initiation and maintenance.

Gabay M, Li Y, Felsher DW. Gabay M, et al. Among authors: felsher dw. Cold Spring Harb Perspect Med. 2014 Jun 2;4(6):a014241. doi: 10.1101/cshperspect.a014241. Cold Spring Harb Perspect Med. 2014. PMID: 24890832 Free PMC article. Review.

2

Overexpression of MYC causes p53-dependent G2 arrest of normal fibroblasts.

Felsher DW, Zetterberg A, Zhu J, Tlsty T, Bishop JM. Felsher DW, et al. Proc Natl Acad Sci U S A. 2000 Sep 12;97(19):10544-8. doi: 10.1073/pnas.190327097. Proc Natl Acad Sci U S A. 2000. PMID: 10962037 Free PMC article.

3

Sustained loss of a neoplastic phenotype by brief inactivation of MYC.

Jain M, Arvanitis C, Chu K, Dewey W, Leonhardt E, Trinh M, Sundberg CD, Bishop JM, Felsher DW. Jain M, et al. Among authors: felsher dw. Science. 2002 Jul 5;297(5578):102-4. doi: 10.1126/science.1071489. Science. 2002. PMID: 12098700

4

Genomically complex lymphomas undergo sustained tumor regression upon MYC inactivation unless they acquire novel chromosomal translocations.

Karlsson A, Giuriato S, Tang F, Fung-Weier J, Levan G, Felsher DW. Karlsson A, et al. Among authors: felsher dw. Blood. 2003 Apr 1;101(7):2797-803. doi: 10.1182/blood-2002-10-3091. Epub 2002 Nov 27. Blood. 2003. PMID: 12517816 Free article.

5

How cancers escape their oncogene habit.

Giuriato S, Felsher DW. Giuriato S, et al. Among authors: felsher dw. Cell Cycle. 2003 Jul-Aug;2(4):329-32. Cell Cycle. 2003. PMID: 12851484 Review.

6

Defective double-strand DNA break repair and chromosomal translocations by MYC overexpression.

Karlsson A, Deb-Basu D, Cherry A, Turner S, Ford J, Felsher DW. Karlsson A, et al. Among authors: felsher dw. Proc Natl Acad Sci U S A. 2003 Aug 19;100(17):9974-9. doi: 10.1073/pnas.1732638100. Epub 2003 Aug 8. Proc Natl Acad Sci U S A. 2003. PMID: 12909717 Free PMC article.

7

Pharmacological inactivation of MYC for the treatment of cancer.

Felsher DW, Bradon N. Felsher DW, et al. Drug News Perspect. 2003 Jul-Aug;16(6):370-4. doi: 10.1358/dnp.2003.16.6.829309. Drug News Perspect. 2003. PMID: 12973448 Review.

8

Reversibility of oncogene-induced cancer.

Felsher DW. Felsher DW. Curr Opin Genet Dev. 2004 Feb;14(1):37-42. doi: 10.1016/j.gde.2003.12.008. Curr Opin Genet Dev. 2004. PMID: 15108803 Review.

9

Developmental context determines latency of MYC-induced tumorigenesis.

Beer S, Zetterberg A, Ihrie RA, McTaggart RA, Yang Q, Bradon N, Arvanitis C, Attardi LD, Feng S, Ruebner B, Cardiff RD, Felsher DW. Beer S, et al. Among authors: felsher dw. PLoS Biol. 2004 Nov;2(11):e332. doi: 10.1371/journal.pbio.0020332. Epub 2004 Sep 28. PLoS Biol. 2004. PMID: 15455033 Free PMC article.

10

MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer.

Shachaf CM, Kopelman AM, Arvanitis C, Karlsson A, Beer S, Mandl S, Bachmann MH, Borowsky AD, Ruebner B, Cardiff RD, Yang Q, Bishop JM, Contag CH, Felsher DW. Shachaf CM, et al. Among authors: felsher dw. Nature. 2004 Oct 28;431(7012):1112-7. doi: 10.1038/nature03043. Epub 2004 Oct 10. Nature. 2004. PMID: 15475948 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

178 results

Search Page